Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis.

Hadsell DL, Murphy KL, Bonnette SG, Reece N, Laucirica R, Rosen JM.

Oncogene. 2000 Feb 17;19(7):889-98.

2.

Transforming growth factor alpha- and c-myc-induced mammary carcinogenesis in transgenic mice.

Rose-Hellekant TA, Sandgren EP.

Oncogene. 2000 Feb 21;19(8):1092-6. Review.

PMID:
10713695
3.

WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.

Li M, Lewis B, Capuco AV, Laucirica R, Furth PA.

Oncogene. 2000 Feb 21;19(8):1010-9. Review.

4.

Regulation of cell apoptosis by insulin-like growth factor I.

Hadsell DL, Abdel-Fattah G.

Adv Exp Med Biol. 2001;501:79-85. Review.

PMID:
11787734
5.

Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models.

Jamerson MH, Johnson MD, Dickson RB.

Oncogene. 2000 Feb 21;19(8):1065-71. Review.

PMID:
10713691
6.

Studies on mammary carcinogenesis induced by a heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, in mice and rats.

Nagao M, Ushijima T, Watanabe N, Okochi E, Ochiai M, Nakagama H, Sugimura T.

Environ Mol Mutagen. 2002;39(2-3):158-64. Review.

PMID:
11921184
7.

Mutant p53 and genomic instability in a transgenic mouse model of breast cancer.

Murphy KL, Rosen JM.

Oncogene. 2000 Feb 21;19(8):1045-51. Review. No abstract available.

PMID:
10713688
8.

Diet and cancer prevention studies in p53-deficient mice.

Hursting SD, Perkins SN, Phang JM, Barrett JC.

J Nutr. 2001 Nov;131(11 Suppl):3092S-4S. doi: 10.1093/jn/131.11.3092S. Review.

PMID:
11694654
9.

Cancer prevention studies in p53-deficient mice.

Hursting SD, Perkins SN, Donehower LA, Davis BJ.

Toxicol Pathol. 2001 Jan-Feb;29(1):137-41. Review.

PMID:
11215677

Supplemental Content

Support Center